Starpharma Holdings Limited ASX: SPL - US NIH Funded Trial Of VivaGel Commences - Dr Jackie Fairley, CEO

Sydney, July 11, 2007 (ABN Newswire) - Starpharma Holdings Limited (ASX: SPL) - US NIH Funded Trial of VivaGel Commences - Dr Jackie Fairley, CEO; Starpharma Holdings Limited (ASX: SPL) present the following audio webcast regarding "US NIH Funded Trial of VivaGel Commences". You may also download this audio webcast to your computer of portable audio player.

Broadcaster: Starpharma Holdings Limited (ASX: SPL)

Broadcast Title: US NIH Funded Trial of VivaGel Commences

Broadcast Type: Audio stream

Audio webcast Link:


Listen to the Audio stream and view the announcement for Starpharma Holdings Limited (ASX: SPL) below.

http://www.brr.com.au/event/SPL/1305/25087/wmp/203.84.229.42/?